CFO change at Nu Skin (NYSE: NUS) as Chelsea Lantz steps in

Rhea-AI Filing Summary

Nu Skin Enterprises announced that Executive Vice President and Chief Financial Officer James D. Thomas resigned on March 17, 2026 to pursue an outside opportunity. On March 18, 2026, the board appointed Vice President and Corporate Controller Chelsea K. Lantz as Interim CFO while a search for a permanent CFO, including internal and external candidates, is conducted.

Lantz, age 42, has been with Nu Skin since 2011 in various finance and audit roles and became Corporate Controller in 2023. As Interim CFO she will receive a $300,000 annual salary, a target incentive bonus equal to 35% of salary, and a $25,000 stipend for each quarter she serves in the interim role. The company states there are no family relationships or related-person transactions involving her and expects to enter into a standard indemnification agreement. A press release dated March 20, 2026 announces her appointment and highlights her role in cost-improvement efforts that contributed to a significant year-over-year EPS increase.

Insights

Corporate governance analyst

CFO transition appears orderly with an experienced internal interim successor.

Nu Skin is undergoing a key finance leadership change as long-tenured CFO James Thomas resigns and Corporate Controller Chelsea Lantz steps in as Interim CFO. Lantz has deep company experience across internal audit, consolidation and controllership functions.

The board has initiated a formal search including internal and external candidates, suggesting the interim status could change once a permanent CFO is selected. Her compensation package, including a $300,000 base salary and quarterly stipends, reflects added responsibilities but does not indicate unusual terms.

The press release links Lantz to cost-improvement work that produced a significant year-over-year EPS increase, signaling continuity in current financial and operational priorities. The overall picture is of a planned, structured transition rather than an abrupt disruption, though future filings may provide more detail on the long-term CFO choice.

false0001021561NYSE00010215612026-03-172026-03-17

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

March 17, 2026

Date of Report (Date of earliest event reported)

NU SKIN ENTERPRISES, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-12421		87-0565309
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification Number)

75 West Center Street

Provo, Utah 84601

(Address of principal executive offices and zip code)

(801) 345-1000

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A Common Stock, $.001 par value	NUS	New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b), (c), (e)

On March 17, 2026, James D. Thomas notified Nu Skin Enterprises, Inc. (the “Company”) of his resignation from his position as Executive Vice President and Chief Financial Officer, effective on the same date, to pursue an outside opportunity.

On March 18, 2026, the Company’s Board of Directors appointed Chelsea K. Lantz, the Company’s Vice President and Corporate Controller, as Interim CFO. Ms. Lantz is expected to serve until the Company completes a search and appoints a permanent CFO. It is expected that the search will include both internal and external candidates.

Ms. Lantz, age 42, joined the Company in 2011 and has served as the Company’s Vice President and Corporate Controller since 2023. She previously served as Vice President of Internal Audit from 2021 until her promotion to Corporate Controller. She also has served as Consolidation Controller and as an Internal Auditor at the Company. Before joining the Company, she served in the assurance practice at PricewaterhouseCoopers LLP. Ms. Lantz holds a B.A. degree in accounting from Westminster College (now known as Westminster University) and a Master of Accounting degree from Utah State University.

As Interim CFO, Ms. Lantz will earn an annual salary of $300,000, and her target incentive bonus will be 35% of her annual salary. She also will earn a stipend of $25,000 for each quarter she serves as Interim CFO. It is expected that Ms. Lantz will enter into an indemnification agreement with the Company that is substantially identical to the form of indemnification agreement that the Company has entered into with its other executive officers and directors.

Ms. Lantz does not have a family relationship with any of the Company’s directors or executive officers, and the Company does not have any reportable related-person transactions involving Ms. Lantz. Other than as described herein, there are no arrangements or understandings between Ms. Lantz and any other person pursuant to which Ms. Lantz was selected as Interim CFO.

A copy of the related press release, which the Company issued on March 20, 2026, is attached as Exhibit 99.1 hereto.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

99.1	Nu Skin Enterprises’ press release dated March 20, 2026.
104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NU SKIN ENTERPRISES, INC.

(Registrant)

/s/ Chelsea K. Lantz

Chelsea K. Lantz

Chief Financial Officer

Date:  March 20, 2026

Exhibit 99.1

FOR IMMEDIATE RELEASE

Nu Skin Enterprises Appoints Chelsea Lantz as Interim Chief Financial Officer

PROVO, Utah — March 20, 2026 — Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the appointment of Chelsea Lantz as interim Chief Financial Officer, effective immediately. The appointment of Lantz comes after James Thomas stepped down as CFO to pursue an outside opportunity.

“On behalf of our board, management and the entire Nu Skin team, we thank James for his leadership and significant contributions over 16 years at Nu Skin and wish him and his family well in their future pursuits,” said Ryan Napierski, president and CEO. “We have a talented finance team who has led the ongoing work to improve our operational performance and strengthen our balance sheet over the past year. I am excited to work directly with Chelsea to carry forward this important work as we further our transformation to becoming the world’s leading intelligent beauty and wellness leadership opportunity platform.”

Nu Skin’s board of directors has appointed Lantz as interim CFO and has initiated a formal process to appoint a permanent replacement. Lantz joined Nu Skin in 2011 and has worked as corporate controller since 2023, leading the company’s cost-improvement efforts, which resulted in a significant increase in EPS year-over-year. Lantz came to Nu Skin from PricewaterhouseCoopers LLP where she led financial audits and internal controls for public and private companies. She holds a Master of Accounting degree from Utah State University and a bachelor’s degree from Westminster University.

About Nu Skin Enterprises, Inc.

Nu Skin Enterprises Inc. (NYSE: NUS) is an intelligent beauty and wellness company, powered by a dynamic affiliate opportunity platform, which operates in nearly 50 markets worldwide. Backed by more than 40 years of scientific research, the company’s products help people look, feel and live their best with our newly introduced Prysm iO intelligent wellness platform, an award-winning line of beauty device systems and trusted brands in personal care and wellness products. Rhyz is the strategic investment arm of Nu Skin Enterprises, formed in 2018 consisting of synergistic consumer, technology and manufacturing companies focused on innovation within the beauty, wellness and lifestyle categories.

# # #

CONTACTS:

Media: media@nuskin.com, (801) 345-6397

Investors: investorrelations@nuskin.com, (801) 345-3577

Filing Exhibits & Attachments

4 documents

Press Releases

• EX-99.1 PRESS RELEASE DATED MARCH 20, 2026 6.7 KB

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 3.8 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 21.5 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 15.7 KB